Analyzing blood samples for pediatric solid tumors
Official title: Liquid Biopsies in Non-CNS Malignant Pediatric Solid Tumors
Run by Children's Hospital Los Angeles · NCT05068583 · Data updated 2026-11-12
This study is trying to see if blood tests can help track how well treatment is working for kids with solid tumors by looking for cancer-related material in their blood.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 6 Months and up |
| Sex | All |
| Enrollment | 320 (estimated) |
| Sponsor | Children's Hospital Los Angeles Academic / other |
| Locations | 1 site (Los Angeles, California) |
| Status | Recruiting |
| Started | May 8, 2019 |
| Main results expected | May 8, 2029 |
| Study ends | May 8, 2034 |
| Registry record updated | August 21, 2024 |
| Trial ID | NCT05068583 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include children aged 6 months to 21 years with newly diagnosed or relapsed/refractory high-grade solid tumors.
✕Probably not a fit
Patients with CNS malignancies or those under 6 months of age may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to determine the feasibility of detecting tumor-derived material in the blood of pediatric patients with solid tumors. By collecting serial blood samples from patients at various stages of treatment, including before, during, and after therapy, the study will analyze cell-free DNA, RNA, and other tumor-related substances. The findings will be correlated with traditional disease evaluation methods to assess the effectiveness of liquid biopsies in monitoring disease progression and treatment response.
Why it matters
Potential benefit: If successful, this study could provide a non-invasive method for monitoring pediatric solid tumors, improving disease management and patient outcomes.
How similar studies have gone: While liquid biopsies have shown promise in adult cancers, their application in pediatric solid tumors is still being explored, making this approach relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Newly diagnosed, relapsed, or refractory histologically confirmed high grade bone or soft tissue sarcoma or malignant renal, thyroid, germ cell, or hepatic tumors, OR * Healthy individual with no history of cancer or chronic medical problems and \< 21 years of age Exclusion Criteria: * CNS Malignancies * Individuals \< 6 months of age
Where it's running
-
Children's Hospital Los Angeles
Los Angeles, California, United States Recruiting
Study contacts
- Principal investigator: Fariba Navid, MD — Children's Hospital Los Angeles
- Study coordinator: Fariba Navid, MD
- Email: fnavid@chla.usc.edu
- Phone: 323-361-2529
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Comparing oral and intravenous ondansetron for preventing nausea in children undergoing chemotherapy
This study is testing whether a new way of giving ondansetron as a dissolvable film works better than the traditional intravenous method to prevent nausea in children receiving chemotherapy.
-
Smart Inhaler Use at Home for Adolescents with IDD and Asthma
This study tests whether daily use of active smart inhalers at home helps adolescents with intellectual disabilities manage asthma better.
-
Virtual reality to reduce pain and anxiety during interventional radiology procedures
This project will try giving virtual reality headsets to children 8 and older during interventional radiology procedures to see if they reduce pain and anxiety compared with standard care.
-
School-based sleep programs for teens: stepped-care transdiagnostic program versus standard sleep education
This project will test whether a stepped-care transdiagnostic sleep and circadian program delivered in schools helps teens (ages 12–18) sleep better than standard sleep health education.
-
Finalizing an adaptive phone-based support program to help teens take their medications
This pilot will test an adaptive phone-based support program to help adolescents and young adults with chronic conditions take their daily oral medications.
-
Fontan conduit stenting to lower liver stiffness and improve exercise capacity
This project will see if placing a stent in an extracardiac Fontan conduit changes liver stiffness and exercise capacity in 12–21-year-olds with single-ventricle Fontan palliation.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.